Next Generation Sequencing (NGS) Tests – Pipeline Products by Stage of Development 21
Next Generation Sequencing (NGS) Tests – Pipeline Products by Territory 22
Next Generation Sequencing (NGS) Tests – Pipeline Products by Regulatory Path 24
Next Generation Sequencing (NGS) Tests – Pipeline Products by Estimated Approval Date 25
Next Generation Sequencing (NGS) Tests – Ongoing Clinical Trials 26
Next Generation Sequencing (NGS) Tests Companies – Pipeline Products by Stage of Development 27
Next Generation Sequencing (NGS) Tests – Pipeline Products by Stage of Development 31
4bases SA Pipeline Products & Ongoing Clinical Trials Overview 36
BRaVO Screen – Product Status 36
BRaVO Screen – Product Description 36
AccuraGen Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Firefly – Product Status 38
Firefly – Product Description 38
ACT Genomics Co LTD Pipeline Products & Ongoing Clinical Trials Overview 39
ACTSpot NTRK Test – Product Status 39
ACTSpot NTRK Test – Product Description 39
Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 40
ClonoSEQ Assay – Non-Hodgkin’s Lymphoma – Product Status 40
ClonoSEQ Assay – Non-Hodgkin’s Lymphoma – Product Description 40
Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
Next-Generation Sequencing Based Companion Diagnostic Assay – Product Status 42
Next-Generation Sequencing Based Companion Diagnostic Assay – Product Description 42
Pan-Cancer Companion Diagnostic Assay – Product Status 42
Pan-Cancer Companion Diagnostic Assay – Product Description 43
Amoy Diagnostics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
AmoyDx LC10-Essential NGS Panel – Product Status 44
AmoyDx LC10-Essential NGS Panel – Product Description 44
AnchorDx Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
NGS-Based Multi-Cancer Screening Test – Product Status 45
NGS-Based Multi-Cancer Screening Test – Product Description 45
NGS-Based Pan-Cancer Panel – Product Status 46
NGS-Based Pan-Cancer Panel – Product Description 46
NGS-Based Single-Cancer Screening Test – Product Status 46
NGS-Based Single-Cancer Screening Test – Product Description 46
PulmoSeek Plus – Product Status 47
PulmoSeek Plus – Product Description 47
ArcherDx Inc Pipeline Products & Ongoing Clinical Trials Overview 48
AMP-Based Assay – Cancer – Product Status 48
AMP-Based Assay – Cancer – Product Description 48
NextSeq 550Dx System – Blood Cancer CDx Assay – Product Status 49
NextSeq 550Dx System – Blood Cancer CDx Assay – Product Description 49
NextSeq 550Dx System – Minimal Residual Disease Assay – Product Status 49
NextSeq 550Dx System – Minimal Residual Disease Assay – Product Description 49
NextSeq 550Dx System – Solid Tumor CDx Assay – Product Status 50
NextSeq 550Dx System – Solid Tumor CDx Assay – Product Description 50
NGS-Based Companion Diagnostic Assay – Cancer – Product Status 50
NGS-Based Companion Diagnostic Assay – Cancer – Product Description 51
Berry Oncology Corp Pipeline Products & Ongoing Clinical Trials Overview 52
Lai Si Ning – Product Status 52
Lai Si Ning – Product Description 52
BGI Genomics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
SENTIS Colorectal Cancer Panel – Liquid Biopsy Version – Product Status 53
SENTIS Colorectal Cancer Panel – Liquid Biopsy Version – Product Description 53
Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview 54
Idylla NGS Prep Panel – Lung – Product Status 54
Idylla NGS Prep Panel – Lung – Product Description 54
Idylla Retrieve – NGS Hotspot Panel Assay – Product Status 55
Idylla Retrieve – NGS Hotspot Panel Assay – Product Description 55
Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 56
52-Gene Panel Based Companion Diagnostic – Product Status 56
52-Gene Panel Based Companion Diagnostic – Product Description 56
TAm-Seq NGS Lung Cancer Test – Product Status 57
TAm-Seq NGS Lung Cancer Test – Product Description 57
BioLink Pipeline Products & Ongoing Clinical Trials Overview 58
Diagnostic Test – Breast Cancer – Product Status 58
Diagnostic Test – Breast Cancer – Product Description 58
bioTheranostics Inc Pipeline Products & Ongoing Clinical Trials Overview 59
CancerTREATMENT ID – Product Status 59
CancerTREATMENT ID – Product Description 59
Boston University Pipeline Products & Ongoing Clinical Trials Overview 60
Diagnostic Test – Esophageal Adenocarcinoma – Product Status 60
Diagnostic Test – Esophageal Adenocarcinoma – Product Description 60
Buhlmann Laboratories AG Pipeline Products & Ongoing Clinical Trials Overview 61
NGS Targeted Hotspot Panel 16 Kit – Product Status 61
NGS Targeted Hotspot Panel 16 Kit – Product Description 61
Burning Rock Biotech Ltd Pipeline Products & Ongoing Clinical Trials Overview 63
22-Cancer Test – Product Status 63
22-Cancer Test – Product Description 63
OncoCompass Target CDx Test – Tepotinib – Product Status 64
OncoCompass Target CDx Test – Tepotinib – Product Description 64
OverC Multi-Cancer Detection Blood Test Kit – Product Status 64
OverC Multi-Cancer Detection Blood Test Kit – Product Description 65
Burning Rock Biotech Ltd – Ongoing Clinical Trials Overview 66
OverC Multi-Cancer Detection Blood Test Kit – A Prospective Multi-cancer Early-detection and Interventional Study in Asymptomatic Individuals: PREVENT 67
OverC Multi-Cancer Detection Blood Test Kit – A Prospective, Multicenter Study on Development and Validation of the Performance of a cfDNA Methylation-based Model for Early Cancer Detection (Pan-cancer Early Detection project, PREDICT Study) 67
OverC Multi-Cancer Detection Blood Test Kit – Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Myeloma: a Proof of Concept Study 67
OverC Multi-Cancer Detection Blood Test Kit – Assessment of Early Detection Based on Liquid Biopsy in Intracranial Tumors: a Prospective Observational Study 67
OverC Multi-Cancer Detection Blood Test Kit – Burning Rock Pan-cancer Early Detection Project (PREDICT): A Prospective, Multicenter Study to Develop and Validate the Performance of a Cfdna Methylation Based Model on Early Cancer Detection 68
OverC Multi-Cancer Detection Blood Test Kit – Early Detection of Primary Liver Cancer Based on cfDNA Methylation: A Multi-Center Case-Control Study (PRIMe-liver) 68
OverC Multi-Cancer Detection Blood Test Kit – Gynecological Malignancies Earlystage Detection by Multi-omics Based Liquid Biopsy in Peripheral Blood: a Prospective, Extended Validation Study 68
OverC Multi-Cancer Detection Blood Test Kit – Pan-cancer Early-stage Detection by Liquid Biopsy in Peripheral Blood: A Multi-center, Prospective Observational Study 69
Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Mutation Enrichment Kit – Product Status 70
Mutation Enrichment Kit – Product Description 70
CCM Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 71
FLT3 Fusion Bias-free NGS based Companion Diagnostic Assay – Product Status 71
FLT3 Fusion Bias-free NGS based Companion Diagnostic Assay – Product Description 71
ROS1/Trk Fusion Bias-free NGS based Companion Diagnostic Assay – Product Status 71
ROS1/Trk Fusion Bias-free NGS based Companion Diagnostic Assay – Product Description 72
Cerba HealthCare SAS Pipeline Products & Ongoing Clinical Trials Overview 73
Diagnostic Test – Cancer – Product Status 73
Diagnostic Test – Cancer – Product Description 73
Cyclomics BV Pipeline Products & Ongoing Clinical Trials Overview 74
CyclomicsSeq TP53 Diagnostic Kit – Product Status 74
CyclomicsSeq TP53 Diagnostic Kit – Product Description 74
DCGen Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
HOPE – Product Status 75
HOPE – Product Description 75
OncoFREE – Product Status 75
OncoFREE – Product Description 76
Eiken Chemical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
Companion Diagnostic Kit – Non-Small Cell Lung Cancer – Product Status 77
Companion Diagnostic Kit – Non-Small Cell Lung Cancer – Product Description 77
Epic Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 79
DefineMBC – Product Status 79
DefineMBC – Product Description 79
Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview 80
NGS Panel – Bladder Cancer – Product Status 80
NGS Panel – Bladder Cancer – Product Description 80
NGS Panel – Breast Cancer – Product Status 81
NGS Panel – Breast Cancer – Product Description 81
NGS Panel – Colon Cancer – Product Status 81
NGS Panel – Colon Cancer – Product Description 81
NGS Panel – Lung Cancer – Product Status 82
NGS Panel – Lung Cancer – Product Description 82
NGS Panel – Ovarian Cancer – Product Status 82
NGS Panel – Ovarian Cancer – Product Description 83
NGS Panel – Prostate Cancer – Product Status 83
NGS Panel – Prostate Cancer – Product Description 83
FBB Biomed Inc Pipeline Products & Ongoing Clinical Trials Overview 84
Liquid Biopsy Test – Brain Cancer – Product Status 84
Liquid Biopsy Test – Brain Cancer – Product Description 84
Feng Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 85
Xerna TME Companion Diagnostic Assay – Ovarian Cancer – Product Status 85
Xerna TME Companion Diagnostic Assay – Ovarian Cancer – Product Description 85
First Genetics JCS Pipeline Products & Ongoing Clinical Trials Overview 86
F-Genetics NGS System – Oncology – Product Status 86
F-Genetics NGS System – Oncology – Product Description 86
Flomics Biotech Pipeline Products & Ongoing Clinical Trials Overview 87
Colon Cancer Diagnostic Test – Product Status 87
Colon Cancer Diagnostic Test – Product Description 87
Lung Cancer Diagnostic Test – Product Status 88
Lung Cancer Diagnostic Test – Product Description 88
Foundation Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 89
FoundationOne CDx – BI 907828 – Product Status 89
FoundationOne CDx – BI 907828 – Product Description 89
FoundationOne CDx – Taletrectinib – Product Status 90
FoundationOne CDx – Taletrectinib – Product Description 90
FoundationOne CDx – Vitrakvi – Product Status 90
FoundationOne CDx – Vitrakvi – Product Description 91
FoundationOne Liquid CDx – Taletrectinib – Product Status 91
FoundationOne Liquid CDx – Taletrectinib – Product Description 91
Gencurix Inc Pipeline Products & Ongoing Clinical Trials Overview 92
NGS (Next Generation Sequencing) Cancer Test – Product Status 92
NGS (Next Generation Sequencing) Cancer Test – Product Description 92
GeneCast Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 93
Genecast IVD – Comprehensive – Product Status 93
Genecast IVD – Comprehensive – Product Description 93
Genecast IVD – ctDNA Focus – Product Status 94
Genecast IVD – ctDNA Focus – Product Description 94
Genecast IVD – Early Detection Multi-Cancer – Product Status 94
Genecast IVD – Early Detection Multi-Cancer – Product Description 95
Genecast IVD – KNBP – Melanoma – Product Status 95
Genecast IVD – KNBP – Melanoma – Product Description 95
Genecast IVD – MammaPrint – Product Status 96
Genecast IVD – MammaPrint – Product Description 96
Genecast IVD – MRD Solid Tumors – Product Status 96
Genecast IVD – MRD Solid Tumors – Product Description 97
Genecast IVD – RNA Fusion Focus – Product Status 97
Genecast IVD – RNA Fusion Focus – Product Description 97
Geneseeq Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 99
CanScan MCED Kit – Product Status 99
CanScan MCED Kit – Product Description 99
Comprehensive Cancer NGS Diagnostic Kit – Product Status 99
Comprehensive Cancer NGS Diagnostic Kit – Product Description 100
Geneseeq Technology Inc – Ongoing Clinical Trials Overview 101
CanScan MCED Kit – A Prospective, Multicenter Cohort Study of the Multi-omics Liquid Biopsy MCED Test MERCURY in an Average Risk Chinese Population 102
Genetron Health (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 103
Blood-Based Lung EGFR NGS IVD Assay – Product Status 103
Blood-Based Lung EGFR NGS IVD Assay – Product Description 103
Genomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview 104
Liquid Biopsy-Based Bladder Cancer Test – Product Status 104
Liquid Biopsy-Based Bladder Cancer Test – Product Description 104
Next Generation Sequencing Oncotype DX – Prostate Cancer Assay – Product Status 104
Next Generation Sequencing Oncotype DX – Prostate Cancer Assay – Product Description 105
GigaGen Inc Pipeline Products & Ongoing Clinical Trials Overview 106
GigaMune HemeOnc – Product Status 106
GigaMune HemeOnc – Product Description 106
HaploX Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 107
HaploX AiScreening Pan-cancer Early Screening Testing Kit – IVD – Product Status 107
HaploX AiScreening Pan-cancer Early Screening Testing Kit – IVD – Product Description 107
HaploX AiScreening Pan-cancer Early Screening Testing Kit – LDT – Product Status 108
HaploX AiScreening Pan-cancer Early Screening Testing Kit – LDT – Product Description 108
HaploX PulmoScope Pulmonary Nodule Diagnosis Testing Kit – IVD – Product Status 108
HaploX PulmoScope Pulmonary Nodule Diagnosis Testing Kit – IVD – Product Description 109
HaploX PulmoScope Pulmonary Nodule Diagnosis Testing Kit – LDT – Product Status 109
HaploX PulmoScope Pulmonary Nodule Diagnosis Testing Kit – LDT – Product Description 109
HaploX UrineScope Urological Tumor Screening Testing Kit – IVD – Product Status 110
HaploX UrineScope Urological Tumor Screening Testing Kit – IVD – Product Description 110
HaploX UrineScope Urological Tumor Screening Testing Kit – LDT – Product Status 110
HaploX UrineScope Urological Tumor Screening Testing Kit – LDT – Product Description 110
HapOnco PharmCDx NGS Testing Kit – Product Status 111
HapOnco PharmCDx NGS Testing Kit – Product Description 111
HapOnco WESPlus NGS Testing Kit – Pan Cancer – Product Status 111
HapOnco WESPlus NGS Testing Kit – Pan Cancer – Product Description 112
Haystack Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 113
MRD Test – Breast Cancer – Product Status 113
MRD Test – Breast Cancer – Product Description 113
MRD Test – Colorectal Cancer – Product Status 114
MRD Test – Colorectal Cancer – Product Description 114
MRD Test – Lung Cancer – Product Status 114
MRD Test – Lung Cancer – Product Description 114
HTG Molecular Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 116
CNV Navigator – Product Status 116
CNV Navigator – Product Description 116
Ion PGM Dx System – Cancer Assay – Product Status 117
Ion PGM Dx System – Cancer Assay – Product Description 117
Illumina Inc Pipeline Products & Ongoing Clinical Trials Overview 118
Companion Diagnostic Test – Oncology – Product Status 118
Companion Diagnostic Test – Oncology – Product Description 118
TruSight Oncology 500 – TP53 CDx Assay – Product Status 119
TruSight Oncology 500 – TP53 CDx Assay – Product Description 119
TruSight Oncology 500 HRD – Product Status 119
TruSight Oncology 500 HRD – Product Description 119
TruSight Tumor 170 CDx – LOXO-101 – Product Status 120
TruSight Tumor 170 CDx – LOXO-101 – Product Description 120
TruSight Tumor 170 CDx – LOXO-292 – Product Status 120
TruSight Tumor 170 CDx – LOXO-292 – Product Description 121
Illumina Inc – Ongoing Clinical Trials Overview 122
TruSight Oncology 500 HRD – Molecular Landscape Involved in the Onset of Breast Cancer in Patients With Germline BRCA-1/2 Mutations, During or After Therapy With Platinum-based Agents and/or PARP-inhibitors for Ovarian Cancer 123
Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview 124
ProMIS Assay – Product Status 124
ProMIS Assay – Product Description 124
Inivata Ltd Pipeline Products & Ongoing Clinical Trials Overview 125
InVision ctDNA Assay – EGFR-Mutant NSCLC – Product Status 125
InVision ctDNA Assay – EGFR-Mutant NSCLC – Product Description 125
InVision ctDNA Assay – Metastatic Breast Cancer – Product Status 126
InVision ctDNA Assay – Metastatic Breast Cancer – Product Description 126
InVision ctDNA Assay – NSCLC – Product Status 126
InVision ctDNA Assay – NSCLC – Product Description 127
InVision ctDNA Assay – Pancreatic Cancer – Product Status 127
InVision ctDNA Assay – Pancreatic Cancer – Product Description 127
InVision ctDNA Assay – Stage III/IV NSCLC – Product Status 128
InVision ctDNA Assay – Stage III/IV NSCLC – Product Description 128
RaDaR Assay – Product Status 128
RaDaR Assay – Product Description 128
Inivata Ltd – Ongoing Clinical Trials Overview 130
RaDaR Assay – Liquid Biopsy for Minimal Residual Disease Detection in Head and Necksquamous Cell Carcinoma (LIONESS) Study 131
RaDaR Assay – SURVIVE (Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer) – a Partially Double-blinded, Multi-center, Randomized, Controlled Superiority Study 131
Insight Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 132
NGS Lung Panel Test – Product Status 132
NGS Lung Panel Test – Product Description 132
Invivoscribe Inc Pipeline Products & Ongoing Clinical Trials Overview 133
B-cell Immuno-Oncology Assay Kit – Product Status 133
B-cell Immuno-Oncology Assay Kit – Product Description 133
LymphoTrack Dx TRB Assay – PGM – Product Status 134
LymphoTrack Dx TRB Assay – PGM – Product Description 134
MiSeqDx – Cancer Diagnostic Test – Product Status 134
MiSeqDx – Cancer Diagnostic Test – Product Description 134
NGS Based Hematologic Malignancy Test – Product Status 135
NGS Based Hematologic Malignancy Test – Product Description 135
T-cell Immuno-Oncology Assay Kit – Product Status 135
T-cell Immuno-Oncology Assay Kit – Product Description 136
IvyGene Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 137
IvyGene Test – Brain Cancer – Product Status 137
IvyGene Test – Brain Cancer – Product Description 137
IvyGene Test – Breast Cancer – Product Status 138
IvyGene Test – Breast Cancer – Product Description 138
IvyGene Test – Colorectal Cancer – Product Status 138
IvyGene Test – Colorectal Cancer – Product Description 139
IvyGene Test – Lung Cancer – Product Status 139
IvyGene Test – Lung Cancer – Product Description 139
IvyGene Test – Nasopharyngeal Carcinoma – Product Status 140
IvyGene Test – Nasopharyngeal Carcinoma – Product Description 140
IvyGene Test – Ovarian Cancer – Product Status 140
IvyGene Test – Ovarian Cancer – Product Description 140
IvyGene Test – Pancreatic Cancer – Product Status 141
IvyGene Test – Pancreatic Cancer – Product Description 141
Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 142
IntelliGEN Myeloid Test – Product Status 142
IntelliGEN Myeloid Test – Product Description 142
Leto Laboratories Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 144
Companion Diagnostic Test – Solid Tumors – Product Status 144
Companion Diagnostic Test – Solid Tumors – Product Description 144
Prognostic Test – Solid Tumor Immunotherapy – Product Status 145
Prognostic Test – Solid Tumor Immunotherapy – Product Description 145
Lucence Diagnostics Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 146
Lymphoma Subtype Test – Product Status 146
Lymphoma Subtype Test – Product Description 146
MedySapiens Inc Pipeline Products & Ongoing Clinical Trials Overview 147
NEOseq_Cancer – Product Status 147
NEOseq_Cancer – Product Description 147
Mega Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview 148
BRCA1/BRCA2 Gene Mutation Diagnostic Kit – Product Status 148
BRCA1/BRCA2 Gene Mutation Diagnostic Kit – Product Description 148
Cervical Cancer Screening Kit – Product Status 149
Cervical Cancer Screening Kit – Product Description 149
Colorectal Cancer Screening Kit – Product Status 149
Colorectal Cancer Screening Kit – Product Description 149
Gastric Cancer Screening Kit – Product Status 150
Gastric Cancer Screening Kit – Product Description 150
Lung Nodule Auxiliary Diagnostic Kit – Product Status 150
Lung Nodule Auxiliary Diagnostic Kit – Product Description 151
Micronoma Pipeline Products & Ongoing Clinical Trials Overview 152
Oncobiota – Minimal Residual Disease (MRD) Assay – Product Status 152
Oncobiota – Minimal Residual Disease (MRD) Assay – Product Description 152
Oncobiota Companion Diagnostic Test – Product Status 153
Oncobiota Companion Diagnostic Test – Product Description 153
OncobiotaBREAST detect – Product Status 153
OncobiotaBREAST detect – Product Description 154
OncobiotaCOLORECTAL detect – Product Status 154
OncobiotaCOLORECTAL detect – Product Description 154
OncobiotaLIVER detect – Product Status 155
OncobiotaLIVER detect – Product Description 155
OncobiotaOVARIAN detect – Product Status 155
OncobiotaOVARIAN detect – Product Description 156
MolecularMD Corp Pipeline Products & Ongoing Clinical Trials Overview 157
NGS Assay – Lung Cancer – Product Status 157
NGS Assay – Lung Cancer – Product Description 157
Notch1 NGS Test – Chronic Lymphocytic Leukemia – Product Status 158
Notch1 NGS Test – Chronic Lymphocytic Leukemia – Product Description 158
NGeneBio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 159
Analytical Performance Test – Solid Cancer – Product Status 159
Analytical Performance Test – Solid Cancer – Product Description 159
BRCA NGS Panel For PARP Inhibitor CDx Test – Product Status 160
BRCA NGS Panel For PARP Inhibitor CDx Test – Product Description 160
Clinical Performance Test – Solid Cancer – Product Status 160
Clinical Performance Test – Solid Cancer – Product Description 161
Laboratory-Developed Test – Hematologic Malignancy – Product Status 161
Laboratory-Developed Test – Hematologic Malignancy – Product Description 161
LUNGaccuTest – Product Status 162
LUNGaccuTest – Product Description 162
SOLIDaccuCDx SOMATIC – Product Status 162
SOLIDaccuCDx SOMATIC – Product Description 163
SOLIDaccuTest – Talazoparib – Product Status 163
SOLIDaccuTest – Talazoparib – Product Description 163
Novigenix SA Pipeline Products & Ongoing Clinical Trials Overview 164
LITOSeekColon – Product Status 164
LITOSeekColon – Product Description 164
LITOseekColonMon – Product Status 165
LITOseekColonMon – Product Description 165
LITOSeekProstate – Product Status 165
LITOSeekProstate – Product Description 165
Precision Diagnostic Test – Neuroendocrine Tumor – Product Status 166
Precision Diagnostic Test – Neuroendocrine Tumor – Product Description 166
Novomics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 167
Companion Diagnostic Test – Lung Cancer – Product Status 167
Companion Diagnostic Test – Lung Cancer – Product Description 167
NuGEN Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 168
Epigenetic Test – Cancer – Product Status 168
Epigenetic Test – Cancer – Product Description 168
NuProbe Inc Pipeline Products & Ongoing Clinical Trials Overview 169
Liquid Biopsy NGS Panel – Non-Small Cell Lung Cancer – Product Status 169
Liquid Biopsy NGS Panel – Non-Small Cell Lung Cancer – Product Description 169
Oncodiag Pipeline Products & Ongoing Clinical Trials Overview 170
Prostadiag – Product Status 170
Prostadiag – Product Description 170
OncoDNA SA Pipeline Products & Ongoing Clinical Trials Overview 171
Companion Diagnostic Assay – Tipifarnib – Product Status 171
Companion Diagnostic Assay – Tipifarnib – Product Description 171
OncoSpire Genomics Pipeline Products & Ongoing Clinical Trials Overview 172
Next-Generation Sequencing Test – Lung Cancer – Product Status 172
Next-Generation Sequencing Test – Lung Cancer – Product Description 172
OrigiMed Inc Pipeline Products & Ongoing Clinical Trials Overview 173
NGS-Based CDx – Larotrectinib – Product Status 173
NGS-Based CDx – Larotrectinib – Product Description 173
OrigiMed Inc – Ongoing Clinical Trials Overview 174
NGS-Based CDx – Larotrectinib – A Prospective Study on NGS-based Comprehensive Genomic ctDNA Panel in NSCLC Treated with Immunotherapy 175
Otsuka Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 176
NextSeq 550Dx System – Acute Lymphoblastic Leukemia Assay – Product Status 176
NextSeq 550Dx System – Acute Lymphoblastic Leukemia Assay – Product Description 176
NextSeq 550Dx System – Acute Myeloid Leukemia Assay – Product Status 177
NextSeq 550Dx System – Acute Myeloid Leukemia Assay – Product Description 177
Pasteur Institute Pipeline Products & Ongoing Clinical Trials Overview 178
HPV RNA-Seq Test – Product Status 178
HPV RNA-Seq Test – Product Description 178
Personal Genome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 179
PGDx elio Plasma Resolve – Product Status 179
PGDx elio Plasma Resolve – Product Description 179
Precision Diagnostics Tool – Product Status 180
Precision Diagnostics Tool – Product Description 180
Pillar Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 181
IVD Onco/Reveal Dx Assay – Blood Cancer – Product Status 181
IVD Onco/Reveal Dx Assay – Blood Cancer – Product Description 181
IVD Onco/Reveal Dx Assay – Liquid Biopsy – Product Status 182
IVD Onco/Reveal Dx Assay – Liquid Biopsy – Product Description 182
IVD Onco/Reveal Dx Assay – Tumor Tissue Testing – Product Status 182
IVD Onco/Reveal Dx Assay – Tumor Tissue Testing – Product Description 182
Predicine Inc Pipeline Products & Ongoing Clinical Trials Overview 184
PredicineCARE Companion Diagnostic Test – Product Status 184
PredicineCARE Companion Diagnostic Test – Product Description 184
Predictive Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 185
CertNDx Bladder Cancer Assay – TP53 – Product Status 185
CertNDx Bladder Cancer Assay – TP53 – Product Description 185
PT PathGen Diagnostik Teknologi Pipeline Products & Ongoing Clinical Trials Overview 186
Molecular Genetic Test Kit – Cervical Cancer – Product Status 186
Molecular Genetic Test Kit – Cervical Cancer – Product Description 186
Molecular Genetic Test Kit – Lung Cancer – Product Status 186
Molecular Genetic Test Kit – Lung Cancer – Product Description 187
Molecular Genetic Test Kit – Nasopharynx Cancer – Product Status 187
Molecular Genetic Test Kit – Nasopharynx Cancer – Product Description 187
Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 189
Companion Diagnostic Assay – Precancerous Cervical Lesions – Product Status 189
Companion Diagnostic Assay – Precancerous Cervical Lesions – Product Description 189
GeneRead QIAact Lung All-in-One Assay – Product Status 190
GeneRead QIAact Lung All-in-One Assay – Product Description 190
GeneReader NGS System – BRCA Liquid Biopsy Assay – Product Status 190
GeneReader NGS System – BRCA Liquid Biopsy Assay – Product Description 191
GeneReader NGS System – Leukemia – Product Status 191
GeneReader NGS System – Leukemia – Product Description 191
GeneReader NGS System – MPN – Product Status 191
GeneReader NGS System – MPN – Product Description 192
QIAact Breast Panel (Expanded) – Product Status 192
QIAact Breast Panel (Expanded) – Product Description 192
QIAact Lung Panel (CNV And Fusion) – Product Status 193
QIAact Lung Panel (CNV And Fusion) – Product Description 193
QIAact Onco-Heme Panel – Myeloid – Product Status 193
QIAact Onco-Heme Panel – Myeloid – Product Description 193
Quantgene Inc Pipeline Products & Ongoing Clinical Trials Overview 195
DEEPGEN Panel – Product Status 195
DEEPGEN Panel – Product Description 195
Liquid Biopsy Assay – Cancer Recurrence Monitoring – Product Status 196
Liquid Biopsy Assay – Cancer Recurrence Monitoring – Product Description 196
Liquid Biopsy Assay – Minimum Residual Disease – Product Status 197
Liquid Biopsy Assay – Minimum Residual Disease – Product Description 197
Liquid Biopsy Companion Diagnostic Assay – Product Status 198
Liquid Biopsy Companion Diagnostic Assay – Product Description 198
Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 199
Prognostic Tool – ER+ Breast Cancer – Product Status 199
Prognostic Tool – ER+ Breast Cancer – Product Description 199
RealSeq Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 200
RealSeq-SC – Product Status 200
RealSeq-SC – Product Description 200
Rhodx Inc Pipeline Products & Ongoing Clinical Trials Overview 201
Liquid Biopsy Test – Cancer – Product Status 201
Liquid Biopsy Test – Cancer – Product Description 201
Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 202
AVENIO Blood Test – Product Status 202
AVENIO Blood Test – Product Description 202
AVENIO Tissue Test – Product Status 202
AVENIO Tissue Test – Product Description 203
SeqOne SAS Pipeline Products & Ongoing Clinical Trials Overview 204
SeqOne HRD Test – Product Status 204
SeqOne HRD Test – Product Description 204
Silicon Biosystems S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 205
Genomic Cancer Assay – Product Status 205
Genomic Cancer Assay – Product Description 205
Sophia Genetics SA Pipeline Products & Ongoing Clinical Trials Overview 206
Myeloid Solution – Product Status 206
Myeloid Solution – Product Description 206
SOPHiA DDM Dx RNAtarget Oncology Solution – Product Status 207
SOPHiA DDM Dx RNAtarget Oncology Solution – Product Description 207
Sostos LLC Pipeline Products & Ongoing Clinical Trials Overview 208
CATOS-LU – Product Status 208
CATOS-LU – Product Description 208
Spectrum Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 209
Liquid Biopsy Test – Lung Cancer – Product Status 209
Liquid Biopsy Test – Lung Cancer – Product Description 209
Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 210
Next Generation Sequencing Based Companion Diagnostic Assay – Product Status 210
Next Generation Sequencing Based Companion Diagnostic Assay – Product Description 210
Sysmex Inostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 211
OncoBEAM – Hepatocellular Carcinoma – Product Status 211
OncoBEAM – Hepatocellular Carcinoma – Product Description 211
Tempus Health Inc Pipeline Products & Ongoing Clinical Trials Overview 212
xT-Onco Assay – Product Status 212
xT-Onco Assay – Product Description 212
Tempus Health Inc – Ongoing Clinical Trials Overview 213
xT-Onco Assay – A Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B530, an Autologous Logic-gated Tmod Chimeric Antigen Receptor T Cell (CAR T), in Heterozygous HLA-A*02 Adult Subjects With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression 214
Tempus Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 215
xR IVD – Product Status 215
xR IVD – Product Description 215
Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 217
Companion Next-Generation Sequencing Oncology Test – Product Status 217
Companion Next-Generation Sequencing Oncology Test – Product Description 217
Next Generation Sequencing Assay – Breast Cancer – Product Status 218
Next Generation Sequencing Assay – Breast Cancer – Product Description 218
Next Generation Sequencing Assay – Pancreatic Cancer – Product Status 218
Next Generation Sequencing Assay – Pancreatic Cancer – Product Description 219
Next Generation Sequencing Assay – Prostate Cancer – Product Status 219
Next Generation Sequencing Assay – Prostate Cancer – Product Description 219
NGS Panel – Pediatric Cancer – Product Status 220
NGS Panel – Pediatric Cancer – Product Description 220
Oncomine Precision Assay – Non-Small Cell Lung Cancer – Product Status 220
Oncomine Precision Assay – Non-Small Cell Lung Cancer – Product Description 220
Oncomine Precision Assay – Solid Tissue Tumor – Product Status 221
Oncomine Precision Assay – Solid Tissue Tumor – Product Description 221
Thermo Fisher Scientific Inc – Ongoing Clinical Trials Overview 222
Oncomine Precision Assay – Non-Small Cell Lung Cancer – A Multi-center Observational Study to Evaluate the Clinical Utility of Returning Genomic Aberration Results Using the Oncomine Precision Assay in Advanced or Metastatic Non-small Cell Lung Cancer within the Exactis Network 223
Trivitron Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 224
NGS Based Test – Cancer – Product Status 224
NGS Based Test – Cancer – Product Description 224
TwinStrand Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 225
TwinStrand DuplexSeq – Product Status 225
TwinStrand DuplexSeq – Product Description 225
University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 226
Oral Cancer Saliva Test – Product Status 226
Oral Cancer Saliva Test – Product Description 226
University of Michigan Rogel Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 227
UPSeq Test – Product Status 227
UPSeq Test – Product Description 227
